| Nov 19 |
Regeneron Pharmaceuticals, Inc. (REGN): Among the Best Genomics Stocks to Buy Right Now
|
| Nov 19 |
Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)
|
| Nov 19 |
Regeneron: The Biotech Stock To Buy Now
|
| Nov 19 |
Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3
|
| Nov 18 |
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
|
| Nov 15 |
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
|
| Nov 15 |
Regeneron, Sanofi say resubmitted application to expand Dupixent label accepted in U.S.
|
| Nov 15 |
Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
|
| Nov 14 |
Citi initiates coverage on 5 new biotech stocks
|
| Nov 14 |
2 Top Growth Stocks to Buy on the Dip
|
